Phenserine, >=98% (HPLC), solid

Phenserine, >=98% (HPLC), solid

Biochem/physiol Actions

(-)-Phenserine, a phenylcarbamate derivative, is a selective, non-competitive inhibitor of acetylcholinesterase (AChE). (-)-Phenserine produces rapid, potent, and long-lasting AChE inhibition, in vivo. It is significantly less toxic than (-)-physostigmine. (-)-Phenserine improves cognitive performance in both young learning-impaired and elderly rats. Reduced secretion of β-amyloid (Abeta) has been observed in cell lines exposed to (-)-phenserine, occurring through translational regulation of β-amyloid precursor protein (beta-APP) mRNA via a non-cholinergic mechanism. These in vitro findings appear to translate in vivo into animal models and humans.

Features and Benefits

This compound is featured on the Acetylcholine Synthesis and Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Packaging

25, 100 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3573516 Phenserine, >=98% (HPLC), solid off-white 100 PBHFNBQPZCRWQP-QUCCMNQESA-N 1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1 SIGMA-ALDRICH DMSO: >5 mg/mL, H2O: ﹤2 mg/mL solid ≥98% (HPLC)
£632.36 (exc VAT) per 100MG
-
+
3573517 Phenserine, >=98% (HPLC), solid off-white 100 PBHFNBQPZCRWQP-QUCCMNQESA-N 1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1 SIGMA-ALDRICH DMSO: >5 mg/mL, H2O: ﹤2 mg/mL solid ≥98% (HPLC)
£167.14 (exc VAT) per 25MG
-
+